ONCOCROSS

  • ONCOCROSS

    • Mission

    • History

    • Leadership

    • Scientific Advisory Board

  • Technology

    • Platform

    • ONCOCROSS AI Platform

      • RAPTOR AI™

      • ONCO-RAPTOR AI™

      • ONCOfind AI™

    • in vitro / in vivo analysis

  • Collaboration

    • New Indication

    • Optimal Cancer Type Identification

    • CUP Primary Site Identification

  • News/IR

    • Announcement

    • Press

    • Regulatory Disclosure

    • Stock Information

CONTACT US
한
  • ONCOCROSS

    • Mission

    • History

    • Leadership

    • Scientific Advisory Board

  • Technology

    • Platform

    • ONCOCROSS AI Platform

      • RAPTOR AI™

      • ONCO-RAPTOR AI™

      • ONCOfind AI™

    • in vitro / in vivo analysis

  • Collaboration

    • New Indication

    • Optimal Cancer Type Identification

    • CUP Primary Site Identification

  • News/IR

    • Announcement

    • Press

    • Regulatory Disclosure

    • Stock Information

  • 한
  • EN
CONTACT US
  • Main
  • News/IR
  • Regulatory Disclosure

Regulatory Disclosure

18 Posts
  • Semi-Annual Report (2025.06)

    08-14-2025
  • Results of issuance(Voluntary Disclosure)

    07-25-2025
  • Other Management Information(Voluntary Disclosure)

    07-22-2025
  • Report on Major Issues/Reporting Obligations to the KRX

    07-21-2025
  • Quarterly Report (2025.03)

    05-15-2025
  • Report on Significant Holdings of Stocks, etc.

    04-25-2025
  • Report on the Grant of Stock Options

    04-15-2025
  • Outcomes of Annual Meeting of Shareholders (2025)

    03-28-2025
  • Change of CEO

    03-28-2025
  • Annual Report (2024.12)

    03-20-2025
  • Submission of Audit Report

    03-20-2025
  • Announcement of Convocation of General Meeting of Shareholders (2025)

    03-13-2025
  • 1
  • 2

Please enter a prompt

ONCOCROSS
CEO
Yi Rang KIM / Jihoon KANG
Address
#905 7 Beobwon-ro 11-gil, Songpa-gu, Seoul, 05836, Korea
Tel
02-717-9967
Fax
02-867-9968
Email
oncocross@oncocross.com
Terms & Conditions Privacy Policy Cookie Policy
ⓒ ONCOCROSS CO., LTD. All Rights Reserved.